The Swiss stock market opened slightly lower, with UBS and Sandoz in the spotlight following strong quarterly results. The SMI fell by 0.16% to 12,081.41 points, while UBS rose 3.2% and Sandoz gained 2.2%. In contrast, Swatch and Richemont faced declines after negative reports.
The Swiss stock market opened slightly lower, with UBS and Sandoz in the spotlight following strong quarterly results. The SMI fell 0.16% to 12,081.41 points, while UBS rose 3.2% and Sandoz gained 2.2%. In contrast, Swatch and Richemont faced declines after negative reports.
The Swiss stock exchange is experiencing a busy reporting season, with UBS reporting a better-than-expected billion-euro profit and Sandoz raising its sales outlook. The SMI is up 0.27% in pre-market trading, while Novartis received FDA approval for a leukemia treatment. Meanwhile, Swatch faces a "Sell" rating, and Kühne+Nagel sees a decline after a target cut.
The Swiss stock exchange is active with the reporting season, highlighted by UBS exceeding profit expectations and Sandoz raising its sales outlook. The SMI is up 0.27%, while major US tech firms, including Microsoft and Meta, are set to report, amid anticipation for the US labor market data. Novartis received FDA approval for a leukemia treatment, while Swatch and Richemont received mixed ratings from Berenberg.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
